Sprint Bioscience AB (SPRINT) — Free Cash Flow Generation Index
Sprint Bioscience AB (SPRINT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of Skr115.78 Million represents 1% of operating cash flow (Skr115.84 Million). Read Sprint Bioscience AB balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Sprint Bioscience AB across 4 annual periods. Explore Sprint Bioscience AB capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sprint Bioscience AB (2015–2025)
Year-by-year Free Cash Flow Generation Index for Sprint Bioscience AB. For the full company profile including market capitalisation, see Sprint Bioscience AB market capitalisation.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr83.44 Million | Skr83.53 Million | Skr94.00K | ▲ +11.9% |
| 2023 | 0.89x | Skr20.42 Million | Skr22.87 Million | Skr2.45 Million | ▲ +458.9% |
| 2016 | -0.25x | Skr-1.97 Million | Skr7.93 Million | Skr9.91 Million | ▲ +96.1% |
| 2015 | -6.43x | Skr-5.36 Million | Skr833.54K | Skr6.19 Million | — |